Bleichroeder’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44.7K Hold
825
– – ﹤0.01% 100
2026
Q2
$34.7K Hold
825
– – 0.01% 72
2026
Q1
$21.8K Hold
825
– – ﹤0.01% 73
2025
Q4
$23.9K Hold
825
– – ﹤0.01% 69
2025
Q3
$22.9K Hold
825
– – ﹤0.01% 67
2025
Q2
$20.1K Hold
825
– – ﹤0.01% 70
2025
Q1
$17.1K Hold
825
– – ﹤0.01% 73
2024
Q4
$19.4K Hold
825
– – ﹤0.01% 70
2024
Q3
$21.1K Hold
825
– – 0.01% 67
2024
Q2
$19.4K Hold
825
– – 0.01% 68
2024
Q1
$23.7K Hold
825
– – 0.01% 71
2023
Q4
$27.1K Hold
825
– – 0.01% 65
2023
Q3
$23K Hold
825
– – 0.01% 60
2023
Q2
$28.1K Hold
825
– – 0.01% 68
2023
Q1
$24.8K Hold
825
– – 0.01% 66
2022
Q4
$23.3K Hold
825
– – 0.01% 69
2022
Q3
$27K Hold
825
– – 0.01% 77
2022
Q2
$26K Buy
825
+500
+154% +$17.5K 0.01% 83
2022
Q1
$15K Buy
+325
New +$15.5K ﹤0.01% 106

Other funds holding ARKG

Bleichroeder's ARKG Position: Q3 2026 in Review

Bleichroeder held its ARK Genomic Revolution ETF (ARKG) position steady in Q3 2026 at 825 shares worth $44.7K. The position accounts for ﹤0.01% of the portfolio, ranked #100.

Bleichroeder first reported a position in ARKG in Q1 2022 and has held it in 19 quarters since. 260 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • Bleichroeder held 825 shares of ARK Genomic Revolution ETF worth $44.7K as of Q3 2026.
  • Bleichroeder left its ARK Genomic Revolution ETF share count unchanged in Q3 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Bleichroeder's portfolio in Q3 2026, its #100 holding.
  • Bleichroeder first reported a position in ARK Genomic Revolution ETF in Q1 2022 and has held it in 19 quarters since.
  • 260 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.